LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NYSE: PBYI), a biopharmaceutical company,
announced the closing of an underwritten public offering of 4,312,500
shares of its common stock at a price to the public of $40.00 per share.
The shares of common stock issued in the offering included 562,500
shares of common stock issued upon the exercise in full by the
underwriters of their option to purchase additional shares. The net
proceeds from the offering weremore...